Charlene Liao
Company: Immune-Onc Therapeutics Inc.
Job title: CEO
Seminars:
Targeting Multiple Immune Cell Types to Promote Maximum Efficacy 9:00 am
Shaping the ideal combination pathway to maximize the overall efficacy of myeloid-targeting therapies Incorporating immunomodulatory elements to enhance the immune response against target cells Considering the dynamic nature of the TME and customizing combination pathways to address its specific characteristicsRead more
day: Conference Day 1